← Back to patent-cliff list
米非司酮
Tier C — Watch / tradeMifepristone
丹科实验室
Originator
1987
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PR
Brand：Pictovir、Mifeprex、Korlym、Corlux
Indications (approved)：库欣综合征、终止妊娠
Regional status
US
批准上市
2000-09-28
EU
批准上市
1987-01-01
China
批准上市
1995-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Mifepristone?
Approved indications include: 库欣综合征, 终止妊娠.
When does the Mifepristone patent expire?
No public expiry year is available for Mifepristone yet; this page updates once verified.
How do I get a quote for Mifepristone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25